Your browser doesn't support javascript.
loading
Letter to the Editor Re: Treatment Progress of Compound Kushen Injection and Gemcitabine in Postoperative Patients with Bladder Cancer and Selection of Drug Delivery Mode.
Tian, Fang; Wei, Yujing; Wang, Tengfei; Yuan, Xinmei; Zheng, Shuyun; Sun, Jie.
Affiliation
  • Tian F; Department of Oncology, Feicheng People's Hospital, 271600 Taian, Shandong, China.
  • Wei Y; Department of Pharmacy, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Medical Group), 266000 Qingdao, Shandong, China.
  • Wang T; Pharmacy Intravenous Admixture Services, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Medical Group), 266000 Qingdao, Shandong, China.
  • Yuan X; Department of Blood Transfusion, Jinan Zhangqiu District People's Hospital, 250000 Jinan, Shandong, China.
  • Zheng S; Department of Pediatrics, Jinan Zhangqiu District People's Hospital, 250200 Jinan, Shandong, China.
  • Sun J; Operation Room, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), 266033 Qingdao, Shandong, China.
Arch Esp Urol ; 77(4): 453-454, 2024 May.
Article in En | MEDLINE | ID: mdl-38840292
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Deoxycytidine / Gemcitabine Limits: Humans Language: En Journal: Arch Esp Urol Year: 2024 Document type: Article Affiliation country: China Country of publication: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Deoxycytidine / Gemcitabine Limits: Humans Language: En Journal: Arch Esp Urol Year: 2024 Document type: Article Affiliation country: China Country of publication: Spain